Ryman Healthcare (RYM) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
14 May, 2026Overview and objectives
Leading operator in retirement living and aged care with 49 villages and over 15,300 residents across New Zealand and Australia.
Business transformation underway, focusing on operational reset, governance refresh, and capital management reset.
New leadership team and board with extensive experience in transformation and value creation.
Strategic priorities include releasing cash, sustainable business improvement, and disciplined growth.
Positioned to benefit from demographic trends and increasing demand for aged care services.
Trading update
Sales volumes steady through 3Q25, but applications declined, impacting projected sales in 4Q25 and 1H26.
Targeted incentives and tactical pricing expected to drive sales recovery in 2H26.
Operational levers include targeted marketing, flexible pricing, and improved customer journey to release cash from stock.
Business transformation
Board and executive team refreshed, with a new CEO and a shift to a functional structure.
Focus on releasing over $500m cash in 3-5 years through stock sell-down, pausing new developments, and increasing resident capital in care.
Targeting $100-150m annualised cash improvement via operational efficiencies and leveraging care model.
Disciplined growth through staged developments, portfolio optimisation, and exploring consolidation opportunities, especially in Australia.
Latest events from Ryman Healthcare
- Targeting NZD 150m cash flow uplift and NZD 500m cash release by FY 2029, with resumed dividends.RYM
Investor Day 20264 Feb 2026 - Strategic reset, board overhaul, and $1B equity raise drive focus on value recovery.RYM
AGM 20253 Feb 2026 - Cash flow up, profit down, dividends suspended, new villages opened, sector funding tight.RYM
AGM 20242 Feb 2026 - Net profit dropped 50% to $94.4M amid higher costs, negative cash flow, and accounting changes.RYM
H1 202512 Jan 2026 - First positive free cash flow in a decade, with revenue up 13% but a net loss of $45.2m.RYM
H1 202627 Nov 2025 - Record build, improved cash flow, and cost savings set up for disciplined FY26 growth.RYM
H2 202520 Nov 2025